Lupin Diagnostics Limited, a active public limited company, was established on 17 March 2011 in Mumbai, Maharashtra, India. Engaging in diagnostic centers & pathology labs within the manufacturing sector, it holds CIN: U24100MH2011PLC214885. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹220.00 Cr and a paid-up capital of ₹73.66 Cr.
Formerly known as Lupin Healthcare Limited. It upholds a compliant status. Employing 556 professional, Its leadership includes Swaminathan Ramesh (Director), Nilesh Deshbandhu Gupta (Managing Director), Manju Deshbandhu Gupta (Director). Past directors included Sunil Makharia, Swaminathan Ramesh, Ramessh Kr Khaitan. Its latest AGM occurred on 30 July 2025, with the balance sheet filed on 31 March 2025. It is based at Kalpataru Inspire, 3Rd Floor Off Western Express Highway, Santacuz(Ea, St)., Mumbai, Maharashtra, 400055.
U24100MH2011PLC214885
214885
17 March 2011
₹220.00 Cr
₹73.66 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Lupin Diagnostics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swaminathan Ramesh | Director | 28 Nov 2023 | Current |
| Nilesh Deshbandhu Gupta | Managing Director | 26 Aug 2011 | Current |
| Manju Deshbandhu Gupta | Director | 12 May 2022 | Current |
| Rajeev Sibal | Director | 15 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Cfo | 15 Apr 2025 | Past |
| Pramod Abcsdd | Additional Director | 14 Jul 2024 | Past |
| Pramod Abcsdd | Director | 10 Aug 2018 | Past |
| Pramod Abcsdd | Director | 01 Dec 2020 | Past |
| Pramod Abcsdd | Director | 21 Nov 2022 | Past |
| Pramod Abcsdd | Director | 10 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lupin Diagnostics Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 442.48% increase. The company also saw a substantial fall in profitability, with a 140.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 338.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Lupin Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Lupin Diagnostics has a workforce of 556 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lupin Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lupin Diagnostics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lupin Diagnostics Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records. was completed.
The activity Vishal Rathi was appointed as a Cfo was appointed as a Cfo on 02 May 2025 & has been associated with this company since 7 months 15 days . was completed.
Progress on Lupin Diagnostics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity Amit Kumar Gupta was appointed as a Company Secretary was appointed as a Company Secretary on 11 Sep 2024 & has been associated with this company since 1 year 3 months . was completed.
Swaminathan Ramesh was appointed as a Director was appointed as a Director on 28 Nov 2023 & has been associated with this company since 2 years 18 days . was recorded as a recent event.
Progress on Manju Deshbandhu Gupta was appointed as a Director was appointed as a Director on 12 May 2022 & has been associated with this company since 3 years 7 months . was documented.
Funke has previously worked in leadership roles at organisations such as Fresenius Kabi and Strides Pharma Science. In his leadership roles, Funke has managed large-scale technical operations and manufacturing networks across 27 sites in 19 countries, overseeing production value exceeding $ 2 billion and leading teams of over 12,500 employees, the press release said. Funke holds an engineering degree from South Westphalia University of Applied Sciences, Germany..
The product is a generic equivalent of AstraZeneca AB's Qtern tablets.
The CIN of Lupin Diagnostics Limited is U24100MH2011PLC214885.
Lupin Diagnostics Limited is headquartered at Kalpataru Inspire, 3Rd Floor Off Western Express Highway, Santacuz(Ea, St)., Mumbai, Maharashtra, 400055.
Lupin Diagnostics Limited was incorporated on 17 March 2011.
The current directors of Lupin Diagnostics Limited are
The primary industry of Lupin Diagnostics Limited is Manufacturing.
Lupin Diagnostics Limited is unlisted.
The authorized capital of Lupin Diagnostics Limited is ₹220.00 Cr, and the paid-up capital is ₹73.66 Cr.
The compliance status of Lupin Diagnostics Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX